Reply to the Letter, "Methotrexate myelopathy: A mimicker of subacute combined degeneration of the spinal cord"

Brain Dev. 2019 Aug;41(7):646. doi: 10.1016/j.braindev.2019.04.001. Epub 2019 Apr 23.

Authors

Takuji Nakamura¹, Muneaki Matsuo²

Affiliations

¹ Department of Pediatrics, National Hospital Organization Ureshino Medical Center, 2436 Ureshino, Saga 843-0393, Japan. Electronic address: s04211050@gmail.com.
² Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan. Electronic address: matsuo@cc.saga-u.ac.jp.

PMID: 31027652
DOI: 10.1016/j.braindev.2019.04.001

No abstract available

Keywords: Dextromethorphan; Intrathecal methotrexate; Methotrexate myelopathy; SACD.

Publication types

Letter
Comment

MeSH terms

Copper
Folic Acid
Humans
Methotrexate
Spinal Cord
Spinal Cord Diseases*
Subacute Combined Degeneration*

Substances

Copper
Folic Acid
Methotrexate